Diagnosis and management of spinal muscular atrophy: Part 2: Pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics.

Eugenio Maria Mercuri, Elena Stacy Mazzone, Enrico Silvio Bertini, Richard S. Finkel, Oscar H. Meyer, Anita K. Simonds, Mary K. Schroth, Robert J. Graham, Janbernd Kirschner, Susan T. Iannaccone, Thomas O. Crawford, Simon Woods, Francesco Muntoni, Brunhilde Wirth, Jacqueline Montes, Marion Main, Michael Vitale, Brian Snyder, Susana Quijano-Roy, Rebecca Hurst DavisYing Qian, Thomas Sejersen

Risultato della ricerca: Contributo in rivistaArticolo in rivista

172 Citazioni (Scopus)

Abstract

This is the second half of a two-part document updating the standard of care recommendations for spinal muscular atrophy published in 2007. This part includes updated recommendations on pulmonary management and acute care issues, and topics that have emerged in the last few years such as other organ involvement in the severe forms of spinal muscular atrophy and the role of medications. Ethical issues and the choice of palliative versus supportive care are also addressed. These recommendations are becoming increasingly relevant given recent clinical trials and the prospect that commercially available therapies will likely change the survival and natural history of this disease.
Lingua originaleEnglish
pagine (da-a)197-207
Numero di pagine11
RivistaNeuromuscular Disorders
DOI
Stato di pubblicazionePubblicato - 2018

Keywords

  • spinal muscular atrophy

Fingerprint

Entra nei temi di ricerca di 'Diagnosis and management of spinal muscular atrophy: Part 2: Pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics.'. Insieme formano una fingerprint unica.

Cita questo